Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
201 participants
OBSERVATIONAL
2006-09-12
2024-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identifying and Measuring Depression in Older Cancer Patients
NCT02174055
A Study of Mental Health Care in People With Cancer
NCT06037954
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
NCT05302375
Effect of Depressin Screening and Care Program at Community Health Center
NCT01626703
Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression
NCT00178087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If you choose to take part, you will be asked to do the following:
1. Fill out questionnaires that ask about:
* Your age, eduction, race, and income
* Your mood
In all, these questionnaires will take about 10 minutes to complete.
2. Answer questions about your mood. This will also take about 10 minutes to complete.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
150 patients will be women with breast cancer (75 early stage and 75 late stage)
No interventions assigned to this group
2
150 will be men with prostate cancer (75 early stage and 75 late stage)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosis of early or late stage prostate cancer, or diagnosis of early or late stage breast cancer
3. Actively engaged in one of the following cancer treatments: chemotherapy, radiation therapy, hormone therapy
4. Able to provide informed consent
5. Ability to converse, write and read English
Exclusion Criteria
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
City of Hope National Medical Center
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Nelson, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.